Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma (Q51922648)
scientific article published in February 2007
Language:
Current Data About Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma
(P31) (Q13442814)
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

(P50) (Q116761102)
(P1545) 12
(P1932) Setsuo Hirohashi
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

(P304) 799-805
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

(P407) (Q1860)

(P433) 3
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

(P478) 13
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

(P577) Thursday, February 1, 2007
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

(P921) (Q356033)
(P887)

(P1433) (Q332253)
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

(P1476) "Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma" (language: en)
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

(P2093) Tetsuya Okano
(P1545) 1
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

Tadashi Kondo
(P1545) 2
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

Kiyonaga Fujii
(P1545) 3
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

Toshihide Nishimura
(P1545) 4
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

Toshimi Takano
(P1545) 5
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

Yuichiro Ohe
(P1545) 6
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

Koji Tsuta
(P1545) 7
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

Yoshihiro Matsuno
(P1545) 8
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

Akihiko Gemma
(P1545) 9
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

Harbumi Kato
(P1545) 10
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

Shoji Kudoh
(P1545) 11
(P248)
(P698) 17289870
(P813) Tuesday, April 17, 2018
(P854) http://europepmc.org/abstract/MED/17289870

other details
description scientific article published in February 2007

External Links
(P356) 10.1158/1078-0432.CCR-06-1654
(P698) 17289870